Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial von Dizman, Nazli, Meza, Luis, Bergerot, Paulo, Alcantara, Marice, Dorff, Tanya, Lyou, Yung, Frankel, Paul, Cui, Yujie, Mira, Valerie, Llamas, Marian, Hsu, Joann, Zengin, Zeynep, Salgia, Nicholas, Salgia, Sabrina, Malhotra, Jasnoor, Chawla, Neal, Chehrazi-Raffle, Alex, Muddasani, Ramya, Gillece, John, Reining, Lauren, Trent, Jeff, Takahashi, Motomichi, Oka, Kentaro, Higashi, Seiya, Kortylewski, Marcin, Highlander, Sarah K., Pal, Sumanta K.

Volltext

Chemoimmunotherapy in urothelial cancer: concurrent or sequential? von Zengin, Zeynep B, Meza, Luis, Pal, Sumanta K, Grivas, Petros

Volltext

Identifying topical influencers on twitter based on user behavior and network topology von Zengin Alp, Zeynep, Gündüz Öğüdücü, Şule

Volltext

Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma von Zengin, Zeynep B., Chehrazi-Raffle, Alex, Salgia, Nicholas J., Muddasani, Ramya, Ali, Sana, Meza, Luis, Pal, Sumanta K.

Volltext

Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy von Castro, Daniela V, Prajapati, Sweta R, Feng, Matthew I, Chan, Elyse H, Lee, Kyle O, Paul, Trishita, Sehgal, Ishaan, Patel, Jalen, Li, Xiaochen, Zengin, Zeynep B, Ebrahimi, Hedyeh, Govindarajan, Ameish, Meza, Luis, Mercier, Benjamin D, Chawla, Neal S, Dizman, Nazli, Philip, Errol J, Hsu, JoAnn, Bergerot, Cristiane D, Chehrazi-Raffle, Alex, Rock, Adam, Liu, Sandy, Tripathi, Abhishek, Dorff, Tanya B, Pal, Sumanta K

Volltext

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial von Ebrahimi, Hedyeh, Dizman, Nazli, Meza, Luis, Malhotra, Jasnoor, Li, Xiaochen, Dorff, Tanya, Frankel, Paul, Llamas-Quitiquit, Marian, Hsu, Joann, Zengin, Zeynep B., Alcantara, Marice, Castro, Daniela, Mercier, Benjamin, Chawla, Neal, Chehrazi-Raffle, Alex, Barragan-Carrillo, Regina, Jaime-Casas, Salvador, Govindarajan, Ameish, Gillece, John, Trent, Jeffrey, Lee, Peter P., Parks, Thomas P., Takahashi, Motomichi, Hayashi, Atsushi, Kortylewski, Marcin, Caporaso, J. Gregory, Lee, Keehoon, Tripathi, Abhishek, Pal, Sumanta K.

Volltext

Tivozanib in renal cell carcinoma: a new approach to previously treated disease von Salgia, Nicholas J., Zengin, Zeynep B., Pal, Sumanta K.

Volltext

Renal Cell Carcinoma of Variant Histology: New Biologic Understanding Leads to Therapeutic Advances von Salgia, Nicholas J, Zengin, Zeynep B, Pal, Sumanta K, Dizman, Nazli

Volltext

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy von Ebrahimi, Hedyeh, Battle, Dena, Salgia, Nicholas J, Zengin, Zeynep B, Dizman, Nazli, Meza, Luis, Bergerot, Cristiane D, Barragan-Carrillo, Regina, Hsu, JoAnn, Castro, Daniela, Mercier, Benjamin, Chawla, Neal, Li, Xiaochen, Tripathi, Abhishek, Liu, Sandy T, Chehrazi-Raffle, Alex, Vaishampayan, Ulka, Staehler, Michael D, Pal, Sumanta K

Volltext

Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic for Renal Cell Carcinoma von Zengin, Zeynep B., Weipert, Caroline, Salgia, Nicholas J., Dizman, Nazli, Hsu, Joann, Meza, Luis, Chehrazi-Raffle, Alexander, Muddasani, Ramya, Salgia, Sabrina, Malhotra, Jasnoor, Chawla, Neal, Philip, Errol J., Kiedrowski, Lesli, Maughan, Benjamin L., Rathi, Nityam, Goel, Divyam, Choueiri, Toni K., Agarwal, Neeraj, Pal, Sumanta K.

Volltext

Front-Line Therapy for Metastatic Renal Cell Carcinoma: A Perspective on the Current Algorithm and Future Directions von Govindarajan, Ameish, Castro, Daniela V, Zengin, Zeynep B, Salgia, Sabrina K, Patel, Jalen, Pal, Sumanta K

Volltext

Racial and ethnic differences in perceptions of germline or somatic DNA sequencing among patients with advanced prostate, urothelial, or kidney cancer von Bergerot, Cristiane Decat, Philip, Errol J., Malhotra, Jasnoor, Bergerot, Paulo Gustavo, Castro, Daniela V., Govindarajan, Ameish, Salgia, Sabrina, Salgia, Meghan, Salgia, Nicholas, Hsu, JoAnn, Meza, Luis, Zengin, Zeynep B., Liu, Sandy, Chehrazi‐Raffle, Alex, Tripathi, Abhishek, Dorff, Tanya, Pal, Sumanta

Volltext

Temporal Characteristics of Adverse Events of Tivozanib and Sorafenib in Previously Treated Kidney Cancer von Zengin, Zeynep B., Pal, Sumanta K., McDermott, David F., Escudier, Bernard, Hutson, Thomas E., Porta, Camillo, Verzoni, Elena, Atkins, Michael B., Kasturi, Vijay, Rini, Brian

Volltext

Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy von Alcantara, Marice B, Tang, Wilson S, Wang, Dongfang, Kaniowski, Damian, Kang, Elaine, Dizman, Nazli, Chehrazi-Raffle, Alexander, Meza, Luis, Zengin, Zeynep, Hall, Jeremy, Hsu, JoAnn, Egelston, Colt, Moreira, Dayson, Horsager, Alan, Pal, Sumanta K, Kortylewski, Marcin

Volltext

Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors von Chawla, Neal S., Sayegh, Nicolas, Tripathi, Nishita, Govindarajan, Ameish, Zengin, Zeynep B., Phillip, Errol J., Dizman, Nazli, Meza, Luis, Muddasani, Ramya, Chehrazi-Raffle, Alexander, Malhotra, Jasnoor, Hsu, JoAnn, Agarwal, Neeraj, Pal, Sumanta K., Tripathi, Abhishek

Volltext

Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study von Bergerot, Cristiane Decat, Philip, Errol J., Govindarajan, Ameish, Castro, Daniela, Malhotra, Jasnoor, Bergerot, Paulo, Salgia, Sabrina, Salgia, Meghan, Salgia, Nicholas, Hsu, JoAnn, Meza, Luis, Zengin, Zeynep B., Liu, Sandy, Chehrazi-Raffle, Alex, Tripathi, Abhishek, Dorff, Tanya, Pal, Sumanta

Volltext

Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration von Zengin, Zeynep B, Henderson, Nicholas C, Park, Joseph J, Ali, Alicia, Nguyen, Charles, Hwang, Clara, Barata, Pedro C, Bilen, Mehmet A, Graham, Laura, Mo, George, Kilari, Deepak, Tripathi, Abhishek, Labriola, Matthew, Rothstein, Shoshana, Garje, Rohan, Koshkin, Vadim S, Patel, Vaibhav G, Schweizer, Michael T, Armstrong, Andrew J, McKay, Rana R, Alva, Ajjai, Dorff, Tanya

Volltext

Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma von Dizman, Nazli, Govindarajan, Ameish, Zengin, Zeynep B., Meza, Luis, Tripathi, Nishita, Sayegh, Nicolas, Castro, Daniela V., Chan, Elyse H., Lee, Kyle O., Prajapati, Sweta, Feng, Matthew, Loo, Vivian, Pace, Makala, O'Brien, Shea, Bailey, Erin, Barragan-Carrillo, Regina, Chehrazi-Raffle, Alex, Hsu, JoAnn, Li, Xiaochen, Agarwal, Neeraj, Pal, Sumanta K.

Volltext

Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles von Govindarajan, Ameish, Salgia, Nicholas J., Li, Haiqing, Castro, Daniela V., Mirzapoiazova, Tamara, Armstrong, Brian, Zhao, Dan, Mercier, Benjamin D., Dizman, Nazli, Chawla, Neal, Zengin, Zeynep, Meza, Luis, Tripathi, Nishita, Sayegh, Nicolas, Chehrazi-Raffle, Alex, Tripathi, Abhishek, Pal, Sumanta K.

Volltext

Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Rese... von Ebrahimi, Hedyeh, Castro, Daniela V, Feng, Matthew I, Prajapati, Sweta R, Lee, Kyle O, Chan, Elyse H, Paul, Trishita, Sehgal, Ishaan, Patel, Jalen, Li, Xiaochan, Zengin, Zeynep B, Meza, Luis, Mercier, Benjamin D, Hsu, JoAnn, Govindarajan, Ameish, Chawla, Neal, Dizman, Nazli, Bergerot, Cristiane D, Rock, Adam, Liu, Sandy, Tripathi, Abhishek, Dorff, Tanya, Pal, Sumanta K, Chehrazi-Raffle, Alexander

Volltext